Wayne Paterson
Chief Executive Officer bei ANTERIS TECHNOLOGIES LTD
Vermögen: 311 483 $ am 31.03.2024
Profil
Wayne G.
Paterson is the founder of Procom RX.
He is currently the Chief Executive Officer, Executive Director & MD at Anteris Technologies Ltd.
and also serves as the Chairman at Constellation Therapeutics Ltd.
Previously, he held positions as a Non-Executive Director at CEPHEID from 2015 to 2016, Director at Merck Serono SA, Director at Admedus Biomanufacturing Pty Ltd., President-Emerging Markets & President-Japan Region at Merck KGaA from 2005 to 2013, and Head-Pharmaceuticals at Roche Pharmaceuticals, Inc. from 1999 to 2005.
He also served as the Head-Commercial Operations at Roche (China) Co. Ltd.
from 1999 to 2005.
Mr. Paterson obtained an undergraduate degree from Queensland University of Technology and an MBA from the University of Southern Queensland.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 15.09.2023 | 20 334 ( 0,11% ) | 311 483 $ | 31.03.2024 |
Aktive Positionen von Wayne Paterson
| Unternehmen | Position | Beginn |
|---|---|---|
| ANTERIS TECHNOLOGIES LTD | Chief Executive Officer | 30.06.2016 |
| Procom RX | Chief Executive Officer | - |
Constellation Therapeutics Ltd.
 Constellation Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Constellation Therapeutics Ltd. operates as medical research institute. The company is headquartered in Australia. | Chairman | - |
Ehemalige bekannte Positionen von Wayne Paterson
| Unternehmen | Position | Ende |
|---|---|---|
| CEPHEID | Director/Board Member | 01.11.2016 |
| MERCK KGAA | Corporate Officer/Principal | 01.01.2013 |
Roche Pharmaceuticals, Inc.
 Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ. | Corporate Officer/Principal | 01.01.2005 |
| Roche (China) Co. Ltd. | Corporate Officer/Principal | 01.01.2005 |
Admedus Biomanufacturing Pty Ltd.
 Admedus Biomanufacturing Pty Ltd. BiotechnologyHealth Technology Part of Anteris Technologies Ltd., Admedus Biomanufacturing Pty Ltd. manufactures bio-implant products. The private company is based in Nedlands, Australia. Admedus Biomanufacturing was acquired by Anteris Technologies Ltd. from Genzyme Australasia Pty Ltd. on December 31, 2013 for $0.09 million. | Director/Board Member | - |
Ausbildung von Wayne Paterson
| Queensland University of Technology | Undergraduate Degree |
| University of Southern Queensland | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| MERCK KGAA | Health Technology |
| ANTERIS TECHNOLOGIES LTD | Health Technology |
| Private Unternehmen | 7 |
|---|---|
CEPHEID
 CEPHEID Medical SpecialtiesHealth Technology CEPHEID develops, manufactures and markets fully-integrated systems that perform genetic analysis. The firm's systems enable molecular testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. The company was founded by Thomas L. Gutshall, William McMillan, Kurt Petersen, Greg Kovacs and M. Allen Northrup on March 4, 1996 and is headquartered in Sunnyvale, CA. | Health Technology |
Roche Pharmaceuticals, Inc.
Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ. | Commercial Services |
Merck Serono SA
 Merck Serono SA Medical SpecialtiesHealth Technology Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland. | Health Technology |
| Roche (China) Co. Ltd. | |
Admedus Biomanufacturing Pty Ltd.
Admedus Biomanufacturing Pty Ltd. BiotechnologyHealth Technology Part of Anteris Technologies Ltd., Admedus Biomanufacturing Pty Ltd. manufactures bio-implant products. The private company is based in Nedlands, Australia. Admedus Biomanufacturing was acquired by Anteris Technologies Ltd. from Genzyme Australasia Pty Ltd. on December 31, 2013 for $0.09 million. | Health Technology |
| Procom RX | |
Constellation Therapeutics Ltd.
Constellation Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Constellation Therapeutics Ltd. operates as medical research institute. The company is headquartered in Australia. | Commercial Services |
